FDA approves Arixtra for thrombosis

The FDA granted marketing approval to Akzo Nobel (Arnhem, the Netherlands) for its Arixtra fondaparinux to prevent deep vein thrombosis in patients undergoing hip fracture, hip replacement or knee rep...